Exploring the role of bacterial virulence factors and host elements in septic arthritis: insights from animal models for innovative therapies

Septic arthritis, characterized as one of the most aggressive joint diseases, is primarily attributed to ( ) and often results from hematogenous dissemination. Even with prompt treatment, septic arthritis frequently inflicts irreversible joint damage, leading to sustained joint dysfunction in a sign...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 15; p. 1356982
Main Author Jin, Tao
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Septic arthritis, characterized as one of the most aggressive joint diseases, is primarily attributed to ( ) and often results from hematogenous dissemination. Even with prompt treatment, septic arthritis frequently inflicts irreversible joint damage, leading to sustained joint dysfunction in a significant proportion of patients. Despite the unsatisfactory outcomes, current therapeutic approaches for septic arthritis have remained stagnant for decades. In the clinical context, devising innovative strategies to mitigate joint damage necessitates a profound comprehension of the pivotal disease mechanisms. This entails unraveling how bacterial virulence factors interact with host elements to facilitate bacterial invasion into the joint and identifying the principal drivers of joint damage. Leveraging animal models of septic arthritis emerges as a potent tool to achieve these objectives. This review provides a comprehensive overview of the historical evolution and recent advancements in septic arthritis models. Additionally, we address practical considerations regarding experimental protocols. Furthermore, we delve into the utility of these animal models, such as their contribution to the discovery of novel bacterial virulence factors and host elements that play pivotal roles in the initiation and progression of septic arthritis. Finally, we summarize the latest developments in novel therapeutic strategies against septic arthritis, leveraging insights gained from these unique animal models.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Elysia A. Masters, U.S. Food and Drug Administration, United States
Neil Zhao, Thomas Jefferson University, United States
Edited by: Axel Cloeckaert, Institut National de recherche pour l’agriculture, l’alimentation et l’environnement (INRAE), France
Reviewed by: Lynn Pezzanite, Colorado State University, United States
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2024.1356982